Cargando…
The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
The global burden of bacterial resistance remains one of the most serious public health concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients require immediate empirical treatment, which may not only be ineffective due to the resistance of MDR bacteria to multi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456941/ https://www.ncbi.nlm.nih.gov/pubmed/37630472 http://dx.doi.org/10.3390/microorganisms11081912 |
_version_ | 1785096820325613568 |
---|---|
author | Mancuso, Giuseppe De Gaetano, Silvia Midiri, Angelina Zummo, Sebastiana Biondo, Carmelo |
author_facet | Mancuso, Giuseppe De Gaetano, Silvia Midiri, Angelina Zummo, Sebastiana Biondo, Carmelo |
author_sort | Mancuso, Giuseppe |
collection | PubMed |
description | The global burden of bacterial resistance remains one of the most serious public health concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients require immediate empirical treatment, which may not only be ineffective due to the resistance of MDR bacteria to multiple classes of antibiotics, but may also contribute to the selection and spread of antimicrobial resistance. Both the WHO and the ECDC consider carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Acinetobacter baumannii (CRAB) to be the highest priority. The ability to form biofilm and the acquisition of multiple drug resistance genes, in particular to carbapenems, have made these pathogens particularly difficult to treat. They are a growing cause of healthcare-associated infections and a significant threat to public health, associated with a high mortality rate. Moreover, co-colonization with these pathogens in critically ill patients was found to be a significant predictor for in-hospital mortality. Importantly, they have the potential to spread resistance using mobile genetic elements. Given the current situation, it is clear that finding new ways to combat antimicrobial resistance can no longer be delayed. The aim of this review was to evaluate the literature on how these pathogens contribute to the global burden of AMR. The review also highlights the importance of the rational use of antibiotics and the need to implement antimicrobial stewardship principles to prevent the transmission of drug-resistant organisms in healthcare settings. Finally, the review discusses the advantages and limitations of alternative therapies for the treatment of infections caused by these “titans” of antibiotic resistance. |
format | Online Article Text |
id | pubmed-10456941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104569412023-08-26 The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” Mancuso, Giuseppe De Gaetano, Silvia Midiri, Angelina Zummo, Sebastiana Biondo, Carmelo Microorganisms Review The global burden of bacterial resistance remains one of the most serious public health concerns. Infections caused by multidrug-resistant (MDR) bacteria in critically ill patients require immediate empirical treatment, which may not only be ineffective due to the resistance of MDR bacteria to multiple classes of antibiotics, but may also contribute to the selection and spread of antimicrobial resistance. Both the WHO and the ECDC consider carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Acinetobacter baumannii (CRAB) to be the highest priority. The ability to form biofilm and the acquisition of multiple drug resistance genes, in particular to carbapenems, have made these pathogens particularly difficult to treat. They are a growing cause of healthcare-associated infections and a significant threat to public health, associated with a high mortality rate. Moreover, co-colonization with these pathogens in critically ill patients was found to be a significant predictor for in-hospital mortality. Importantly, they have the potential to spread resistance using mobile genetic elements. Given the current situation, it is clear that finding new ways to combat antimicrobial resistance can no longer be delayed. The aim of this review was to evaluate the literature on how these pathogens contribute to the global burden of AMR. The review also highlights the importance of the rational use of antibiotics and the need to implement antimicrobial stewardship principles to prevent the transmission of drug-resistant organisms in healthcare settings. Finally, the review discusses the advantages and limitations of alternative therapies for the treatment of infections caused by these “titans” of antibiotic resistance. MDPI 2023-07-27 /pmc/articles/PMC10456941/ /pubmed/37630472 http://dx.doi.org/10.3390/microorganisms11081912 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mancuso, Giuseppe De Gaetano, Silvia Midiri, Angelina Zummo, Sebastiana Biondo, Carmelo The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title | The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title_full | The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title_fullStr | The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title_full_unstemmed | The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title_short | The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan” |
title_sort | challenge of overcoming antibiotic resistance in carbapenem-resistant gram-negative bacteria: “attack on titan” |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456941/ https://www.ncbi.nlm.nih.gov/pubmed/37630472 http://dx.doi.org/10.3390/microorganisms11081912 |
work_keys_str_mv | AT mancusogiuseppe thechallengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT degaetanosilvia thechallengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT midiriangelina thechallengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT zummosebastiana thechallengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT biondocarmelo thechallengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT mancusogiuseppe challengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT degaetanosilvia challengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT midiriangelina challengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT zummosebastiana challengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan AT biondocarmelo challengeofovercomingantibioticresistanceincarbapenemresistantgramnegativebacteriaattackontitan |